CERN Investigators Publish Paper on 5-FU
— Categories: CERN Research Articles Posted on August 6, 2015
A phase I study of the drug called 5-fluorouracil (5-FU) examined the pharmacokinetics, safety, and tolerable dosing for children and young adults with recurrent ependymoma.
In the phase I clinical data, bolus 5-FU is well tolerated.